๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Tumor M2-PK: A promising marker in the diagnosis of gastrointestinal cancer

โœ Scribed by Hardt, Philip D.; Ngoumou, Bona; Rupp, Joachim; Schnell-Kretschmer, Henning; Kloer, Hans U.


Book ID
123356989
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
184 KB
Volume
118
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Tumor type M2 pyruvate kinase (TuM2-PK)
โœ Selma Ugurel; Nellie Bell; Antje Sucker; Anette Zimpfer; Werner Rittgen; Dirk Sc ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 201 KB

## Abstract Proliferating cells express the pyruvate kinase isoenzyme type M2 (M2โ€PK). This enzyme exists as an active tetramer and an inactive dimer. The dimeric form is predominantly found in tumor cells and is therefore termed Tumor M2โ€PK (TuM2โ€PK). TuM2โ€PK molecules are released into the periph

Fecal dimeric M2-pyruvate kinase (tumor
โœ Jinny Jeffery; Stephen J. Lewis; Ruth M. Ayling ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB

Background: Fecal inflammatory markers have been shown to be useful as noninvasive screening tools to differentiate patients with functional from organic bowel pathology. Of these markers calprotectin has been the most intensively studied. More recently, the dimeric isoform of M2-pyruvate kinase (tu